Targeted molecular imaging agents for cellular-scale bimodal imaging

Bioconjugate Chemistry

Volumn 15, Issue 6, 2004, Pages 1488-1495

  Manning, H Charles ^a   Goebel, Timothy ^b   Thompson, Reid C ^a   Price, Ronald R ^c   Lee, Haakil ^c   Bornhop, Darryl J ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE IMAGING; MAGNETIC RESONANCE IMAGING; NEURODEGENERATIVE DISEASES;

BENZODIAZEPINES; BIOCHEMICAL MECHANISMS; BIOCHEMICAL SIGNAL; BREAST CANCER; CANCER DISEASE; CELLULARS; DISEASE STATE; GLIOBLASTOMAS; IMAGING AGENT; OVEREXPRESSIONS;

MOLECULAR IMAGING;

BENZODIAZEPINE RECEPTOR; CHELATE; EUROPIUM N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; GADOLINIUM N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; LANTHANIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DIAGNOSTIC IMAGING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; FLUORESCENCE; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 9244255341     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc049904q     Document Type: Conference Paper

References (48)

1. www.MolecularProbes.com.
2. Ntziachristos, V., and Chance, B. (2001). Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res. 3, 41-46.
3. Licha, K., Riefke, B., Ntziachristos, V., Becker, A., Chance, B., and Semmler, W. (2000). Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: Synthesis, photophysical properties and spectroscopic in vivo characterization. Photochem. Photobiol. 72, 392-398.
4. Hawrysz, D. J., and Sevick-Muraca, E. M. (2000). Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia 2, 388-417.
5. Weissleder, R., and Mahmood, U. (2001). Molecular imaging. Radiology 219, 316-333.
6. Gaietta, G., Deerinck, T. J., Adams, S. R., Bouwer, J., Tour, O., Laird, D. W., Sosinsky, G. E., Tsien, R. Y., and Ellisman, M. H. (2002). Multicolor and electron microscopic imaging of connexin trafficking. Science 296, 503-507.
7. Louie, A. Y., Huber, M. M., Ahrens, E. T., Rothbacher, U., Moats, R., Jacobs, R. E., Fraser, S. E., and Meade, T. J. (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nature Biotechnol. 18, 321-325.
8. Wolfe, H. R., Mendizabal, M., Lleong, E., Cuthbertson, A., Desai, V., Pullan, S., Fujii, D. K., Morrison, M., Pither, R., and Waldman, S. A. (2002). In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C-specific ligand. J. Nuclear Med. 43, 392-399.
9. Lemieux, G. A., Yarema, K. J., Jacobs, C. L., and Bertozzi, C. R. (1999). Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents. J. Am. Chem. Soc. 121, 4278-4279.
10. Kozikowski, A. P., Kotoula, M., Ma, D. W., Boujrad, N., Tuckmantel, W., and Papadopoulos, V. (1997). Synthesis and biology of a 7-nitro-2,1,3- benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: A fluorescent probe for the peripheral-type benzodiazepine receptor. J. Med. Chem. 40, 2435-2439.
11. Li, W. H., Fraser, S. E., and Meade, T. J. (1999). A calcium-sensitive magnetic resonance imaging contrast agent. J. Am. Chem. Soc. 121, 1413-1414.
12. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A. (1999). In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnol. 17, 375-378.
13. Moats, R. A., Fraser, S. E., and Meade, T. J. (1997). A "smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem.-Int. Ed. Engl. 36, 726-728.
14. Mahmood, U., Tung, C. H., and Weissleder, R. (1999). Optical imaging of gene expression using enzyme-specific activatable contrast agents. Radiology 213P, 102-102.
15. Huber, M. M., Staubli, A. B., Kustedjo, K., Gray, M. H. B., Shin, J., Fraser, S. E., Jacobs, R. E., and Meade, T. J. (1998). Fluorescently detectable magnetic resonance imaging agents. Bioconjugate Chem 9, 242-249.
16. Modo, M., Cash, D., Mellodew, K., Williams, S. C. R., Fraser, S. E., Meade, T. J., Price, J., and Hodges, H. (2002). Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 17, 803-811.
17. Josephson, L., Kircher, M. F., Mahmood, U., Tang, Y., and Weissleder, R. (2002). Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjugate Chem 13, 554-560.
18. Casellas, P., Galiegue, S., and Basile, A. S. (2002). Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40, 475-486.
19. Wheeler, K. T., Wang, L. M., Wallen, C. A., Childers, S. R., Cline, J. M., Keng, P. C., Mach, R. H., and Department of Radiology, W. F. U. S.o. M. W.-S. N. C. U.S.A. (2000). Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br. J. Cancer 82 (6), 1223-1232.
20. Carlsson, J., Blomquist, E., Gedda, L., Liljegren, A., Malmstrom, P. U., Sjostrom, A., Sundin, A., Westlin, J. E., Zhao, Q. H., Tolmachev, V., and Lundqvist, H. (1999). Conjugate chemistry and cellular processing of EGF-Dextran. Acta Oncologica 38, 313-321.
21. Szewczyk, A., and Wojtczak, L. (2002). Mitochondria as a pharmacological target. Pharmacol. Rev. 54, 101-127.
22. Starosta-Rubinstein, S., Ciliax, B., Penney, J., McKeever, P., and Young, A. (1987). Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc. Natl. Acad. Sci. U.S.A. 84, 891-895.
23. Garnier, M., Boujrad, N., Oke, B. O., Brown, A. S., Riond, J., Ferrara, P., Shoyab, M., Suarezquian, C. A., and Papadopoulos, V. (1993). Diazepam Binding Inhibitor Is a Paracrine Autocrine Regulator of Leydig-Cell Proliferation and Steroidogenesis - Action Via Peripheral-Type Benzodiazepine Receptor and Independent Mechanisms. Endocrinology 132, 444-458.
24. Alho, H., Varga, V., and Krueger, K. E. (1994). Expression of Mitochondrial Benzodiazepine Receptor and Its Putative Endogenous Ligand in Cultured Primary Astrocytes and C-6 Cells - Relation to Cell-Growth. Cell Growth Differ. 5, 1005-1014.
25. Papadopoulos, V. (2003). Peripheral benzodiazepine receptor: structure and function in health and disease. Ann. Pharm. Fr. 61, 30-50.
26. Messmer, K., and Reynolds, G. P. (1998). Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci. Lett. 241, 53-56.
27. Vowinckel, E., Reutens, D., Becher, B., Verge, G., Evans, A., Owens, T., and Antel, J. P. (1997). PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 50, 345-353.
28. Reutens, D. C., Vowinckel, E., Owens, T., Evans, A. C., and Antel, J. (1997). In vivo and in vitro binding of the peripheral benzodiazepine receptor ligand PK11195 in active lesions of multiple sclerosis and experimental allergic encephalomyelitis. Neurology 48, 2071-2071.
29. Broaddus, W. C., Bennett, J. P., Jr., and Department of Neurosurgery, U.o. V. H. S. C. C. (1990). Peripheral-type benzodiazepine receptors in human glioblastomas: pharmacologic characterization and photoaffinity labeling of ligand recognition site. Brain Res. 518 (1-2), 199-208.
30. Brown, R. C., Degenhardt, B., Kotoula, M., and Papadopoulous, V. (2000). Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis. Cancer Lett. 156, 125-132.
31. Delavoie, F., Li, H., Hardwick, M., Robert, J., Giatzakis, C., Peranzi, G., Yao, Z., Maccario, J., Lacapere, J., and Papadopoulos, V. (2003). In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42, 4506-4519.
32. Miettinen, H., Kononen, J., Haapasalo, H., Helen, P., Sallinen, P., Harjuntausta, T., Helin, H., and Alho, H. (1995). Expression of Peripheral-Type Benzodiazepine Receptor and Diazepam-Binding Inhibitor in Human Astrocytomas - Relationship to Cell-Proliferation. Cancer Res. 55, 2691-2695.
33. Campiani, G., Cappelli, A., Nacci, V., Anzini, M., Vomero, S., Hamon, M., Cagnotto, A., Fracasso, C., Uboldi, C., Caccia, S., Consolo, S., and Mennini, T. (1997). Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. J. Med. Chem 40, 3670-3678.
34. Guo, P. G., Ma, J. G., Li, S. L., Guo, Z. W., Adams, A. L., and Gallo, J. M. (2001). Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer Chemother. Pharmacol. 48, 169-176.
35. Menon, D. K. (personal communication, 2003).
36. Griffin, J. M. M., Skwierawska, A. M., Manning, H. C., Marx, J. N., and Bornhop, D. J. (2001). Simple, high yielding synthesis of trifunctional fluorescent lanthanide chelates. Tetrahedron Lett. 42, 3823-3825.
37. Manning, C. H., Skwierawska, A., Marx, J. N., and Bornhop, D. J. (2003). Rapid removal of benzyloxycarbonyl groups from 1, 4, 7, 10-tetraazacyclododecane derivatives by catalytic transfer hydrogenation. Synth. Commun. 33, 457-461.
38. Manning, H. C., Goebel, T., Marx, J. N., and Bornhop, D. J. (2002). Facile, efficient conjugation of a trifunctional lanthanide chelate to a peripheral benzodiazepine receptor ligand. Org. Lett. 4, 1075-1078.
39. Goodman, M. M. (1999). US Patent 5,998,624.
40. Kovacs, Z., and Sherry, A. D. (1995). A General-Synthesis of 1,7-Disubstituted 1,4,7,10-Tetraazacyclododecanes. J Chem Soc., Chem. Commun. 185-186.
41. Caravan, P., Ellison, J. J., McMurry, T. J., and Lauffer, R. B. (1999). Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 99, 2293-2352.
42. Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B., and Papadopoulos, V. (1999). Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: Correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59, 831-842.
43. Reers, M., Smith, T. W., and Chen, L. B. (1991). J-Aggregate Formation of a Carbocyanine as a Quantitative Fluorescent Indicator of Membrane-Potential. Biochemistry 30, 4480-4486.
44. Dokka, S., Toledo-Velasquez, D., Shi, X. L., Wang, L. Y., and Rojanasakul, Y. (1997). Cellular delivery of oligonucleotides by synthetic import peptide carrier. Pharm. Res. 14, 1759-1764.
45. Pramanik, A., Olsson, M., Langel, U., Bartfai, T., and Rigler, R. (2001). Fluorescence correlation spectroscopy detects galanin receptor diversity on insulinoma cells. Biochemistry 40, 10839-10845.
46. Nunn, A. D., Linder, M. F., Tweedle, M. F. (1997). Can receptors be imaged with MRI. Quart. J. Nuclear Med. 41, 155-162.
47. Hardwick, M., Rone, J., Han, Z. Q., Haddad, B., and Papadopoulos, V. (2001). Peripheral-type benzodiazepine receptor levels correlate with the ability of human breast cancer MDA-MB-231 cell line to grow in SCID mice. Int. J. Cancer 94, 322-327.
48. Sutler, A. P., Maaser, K., Hèopfner, M., Barthel, B., Grabowski, P., Faiss, S., Carayon, P., Zeitz, M., Scherèubl, H., and Medical Clinic I, B. F. U. H. F. U.o. B. B. G. (2002). Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Int. J. Cancer. 102 (4), 318-327.